Antares Pharma: $ATRS A Risky Buy

Antares Pharmaceuticals is a Hot Biopharma Investment Right Now

Antares Pharma
So let's start off with Antares Pharma. Most of my previous stocks that I have written about have done very well in the past few years so I'll continue with that trend with this stock: ATRS.

ATRS FDA Approval PDUFA Date is Oct. 14th

     Antares Pharma

Here's a few web links to help you out on Antares and what they are all about. 

This is what that blogger from Seeking Alpha, Scott Matusow has to say about Antares.  I agree with a commenter that a buyout would be a couple of years down the road.

Antares Pharma (ATRS)

Antares Pharma